Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
Published 2021-12-01 16:15:07
Updated 2023-09-25 02:30:39
Source ICS-CERT
View at NVD,   CVE.org
Vulnerability category: BypassGain privilege

Exploit prediction scoring system (EPSS) score for CVE-2020-10627

0.06%
Probability of exploitation activity in the next 30 days EPSS Score History
~ 25 %
Percentile, the proportion of vulnerabilities that are scored at or less

CVSS scores for CVE-2020-10627

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source First Seen
4.8
MEDIUM AV:A/AC:L/Au:N/C:P/I:P/A:N
6.5
4.9
NIST
7.3
HIGH CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L
2.5
4.7
ICS-CERT
8.1
HIGH CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
2.8
5.2
NIST

CWE ids for CVE-2020-10627

  • The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
    Assigned by: ics-cert@hq.dhs.gov (Secondary)

References for CVE-2020-10627

Products affected by CVE-2020-10627

This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!